1 / 9

Health Care Costs

Health Care Costs. Joseph P. Newhouse. Main Points. The US is an outlier in how much it spends but not its rate of increase Medical advances represent the bulk of the cost increase At the society level it was worth it. Cost Increase in the “G-6”.

king
Télécharger la présentation

Health Care Costs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Health Care Costs Joseph P. Newhouse

  2. Main Points • The US is an outlier in how much it spends but not its rate of increase • Medical advances represent the bulk of the cost increase • At the society level it was worth it

  3. Cost Increase in the “G-6” Annual real % cost increase in the “G-6,” 1960-2003 Average=4.6% Italy missing data before 1988. Germany 1970-02, Japan, UK 1960-02. Source: OECD Health Data 2005, US GDP deflator.

  4. Similar Increases in Real US Cost Annual $/person, by decade Medicare and Medicaid enacted Average = 4.4% Managed care Sources: CMS National Health Accounts. Newhouse, JEP 1992(3), Stat Abst, Ec Rpt Pres. GDP Deflator.

  5. What Do These Data Tell Us? • Any explanation of the cost increase needs to hold across countries and decades • The rate of cost increase is not so dissimilar among countries, so the institutional differences among countries are not the explanation • The US is less of an outlier in the growth rate of cost than in the level of cost

  6. So What Is Raising Costs Everywhere? • Most plausible explanation of most of the increase is the new capabilities of medicine • Aging cannot explain much • A management consultant might say the medical industry keeps developing new lines of business • Think dialysis, transplants, angioplasty, non-invasive imaging, joint replacement, biotech See Newhouse, Journal of Economic Perspectives, 1992.

  7. Was It Worth It? • Life expectancy gains in all countries • 1970-2002: US life expectancy grew 6.6 years, from 70.8 years to 77.4 years • Most of this gain was from improved mortality from cardiovascular disease Life expectancy: Health United States, 2004. Low-tech: Cutler, et al., 1999; Braunwald 1997; generally: Cutler, 2004.

  8. Changes in Heart Disease Treatment Messerli, F. H. et al. N Engl J Med 2005;353:1205-1207 CCUs better managed arrythmias. Thrombolytic agents and angioplasty improved arterial blood flow. Source: Messerli, et al, NEJM, 2005, 353:1206.

  9. The Challenges • How to pay for care for lower income groups • Waste and poor quality in all countries • How to reduce waste without removing valuable services, cutting future innovation

More Related